Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and Doping

Phase 4

Completed

• Conditions: Asthma
• Interventions: Other: blood sample; Other: urine sample

• Registration Number: NCT02655328
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

This study will determine the pharmacokinetic profile of the salbutamol concentration in the urine while athletes are resting or during exercise.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-03
• Primary Completion: 2013-07
• Study Completion: 2013-07
• Study First Submitted: 2015-07-10
• Status Verified: 2016-01
• Study First Submitted QC: 2016-01-11
• Last Update Submitted: 2016-01-11
• Study First Posted: 2016-01-14
• Last Update Posted: 2016-01-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 14

Inclusion Criteria

• patient who hold a license in a sport federation, and do at least 8 hours of sport each week
• asthmatic patient

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
athlete under asthma treatment	blood sample	athlete suffering from asthma blood sample urine sample
athlete under asthma treatment	urine sample	athlete suffering from asthma blood sample urine sample

Primary Outcome Measures

Name	Time	Method
impact of exercise on pharmacokinetics profile	4 days	impact of exercise on pharmacokinetics profile of salbutamol concentration in urine

Trial Locations

Locations (1)

UH Toulouse; 🇫🇷 Toulouse, France